• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Anticonvulsants as Analgesics: 11 Questions on Benefits vs Risks

Slideshow

Sample: Between 2012 and 2016, the number of prescriptions for gabapentin in the US increased by approximately how much?

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

FDA Approves Oral Sulopenem for the Treatment of Uncomplicated Urinary Tract Infections

Patient Care Editorial Staff
October 25th 2024
Article

Oral sulopenem is the first oral penem approved in the US for treating uUTIs in women with limited options.

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Primary Viewpoints: Immunizations with Dr Steven P. Furr

Keith A. Reynolds
October 1st 2024
Podcast

"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with Steven P. Furr, former president of the American Academy of Family Physicians.

Semaglutide Linked with Reduced Risk of Alzheimer Disease in Large Observational Study / image credit Rong Xu, PhD Courtesy Case Western Reserve University

Semaglutide Linked with Reduced Risk of Alzheimer Disease in Large Observational Study

Grace Halsey
October 25th 2024
Article

Semaglutide significantly reduced risk of a first-time diagnosis of AD in a cohort of more than 1 million, suggesting an opportunity for controlled clinical trials.

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair

Sydney Jennings
October 25th 2023
Podcast

Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.

Tsuboya

ACIP Recommends 2nd COVID-19 Shot for Older Adults, Immunocompromised Individuals

Sydney Jennings
October 24th 2024
Article

CDC Director Mandy Cohen endorsed the ACIP's recommendations, which also call for flexible dosing under shared clinical decision making.

Drug Duo Improves COVID-19 Outcomes: Daily Dose / image credit: ©New Africa/AdobeStock

Drug Duo Improves COVID-19 Outcomes: Daily Dose

Sydney Jennings
October 24th 2024
Article

Your daily dose of the clinical news you may have missed.

© 2024 MJH Life Sciences

All rights reserved.